A review of recently published radiotherapy treatment guidelines for bone metastases: Contrasts or convergence?

A review of recently published radiotherapy treatment guidelines for bone metastases: Contrasts or convergence?

Bone metastases are a common manifestation of malignancy, and external beam radiotherapy (EBRT) effectively and safely palliates the pain caused by this clinical circumstance. The myriad of EBRT dosing schemes and complexities involved with coordinating radiotherapy with other interventions necessit...

Full description

Bibliographic Details
Main Authors: Lutz, Stephen, Chow, Edward
Format: Online
Language:English
Published: Elsevier 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723327/
id pubmed-4723327
recordtype oai_dc
spelling pubmed-47233272016-02-23 A review of recently published radiotherapy treatment guidelines for bone metastases: Contrasts or convergence? Lutz, Stephen Chow, Edward Review Article Bone metastases are a common manifestation of malignancy, and external beam radiotherapy (EBRT) effectively and safely palliates the pain caused by this clinical circumstance. The myriad of EBRT dosing schemes and complexities involved with coordinating radiotherapy with other interventions necessitated the need for bone metastases treatment guidelines. Here we compare and contrast the bone metastases radiotherapy treatment guidelines recently published by the American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR). These evaluations acknowledge current controversies in treatment approaches, they evaluate the nuances of ASTRO and ACR task force decision-making regarding standard approaches to care, and they project the upcoming research results that may clarify approaches to palliative radiotherapy for bone metastases. The results of these two dedicated radiotherapy guidelines are compared to the brief mentions of radiotherapy for bone metastases in the National Comprehensive Cancer Network (NCCN) guidelines. Finally, the paper describes how treatment guidelines may influence patterns of care and reimbursement by their use as quality measures by groups such as the National Quality Forum (NQF). Elsevier 2012-05-09 /pmc/articles/PMC4723327/ /pubmed/26909250 http://dx.doi.org/10.1016/j.jbo.2012.04.002 Text en © 2012 Elsevier GmbH. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Lutz, Stephen
Chow, Edward
spellingShingle Lutz, Stephen
Chow, Edward
A review of recently published radiotherapy treatment guidelines for bone metastases: Contrasts or convergence?
author_facet Lutz, Stephen
Chow, Edward
author_sort Lutz, Stephen
title A review of recently published radiotherapy treatment guidelines for bone metastases: Contrasts or convergence?
title_short A review of recently published radiotherapy treatment guidelines for bone metastases: Contrasts or convergence?
title_full A review of recently published radiotherapy treatment guidelines for bone metastases: Contrasts or convergence?
title_fullStr A review of recently published radiotherapy treatment guidelines for bone metastases: Contrasts or convergence?
title_full_unstemmed A review of recently published radiotherapy treatment guidelines for bone metastases: Contrasts or convergence?
title_sort review of recently published radiotherapy treatment guidelines for bone metastases: contrasts or convergence?
description Bone metastases are a common manifestation of malignancy, and external beam radiotherapy (EBRT) effectively and safely palliates the pain caused by this clinical circumstance. The myriad of EBRT dosing schemes and complexities involved with coordinating radiotherapy with other interventions necessitated the need for bone metastases treatment guidelines. Here we compare and contrast the bone metastases radiotherapy treatment guidelines recently published by the American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR). These evaluations acknowledge current controversies in treatment approaches, they evaluate the nuances of ASTRO and ACR task force decision-making regarding standard approaches to care, and they project the upcoming research results that may clarify approaches to palliative radiotherapy for bone metastases. The results of these two dedicated radiotherapy guidelines are compared to the brief mentions of radiotherapy for bone metastases in the National Comprehensive Cancer Network (NCCN) guidelines. Finally, the paper describes how treatment guidelines may influence patterns of care and reimbursement by their use as quality measures by groups such as the National Quality Forum (NQF).
publisher Elsevier
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723327/
_version_ 1613527448213782528

Similar Items